Putnam Investments LLC Clovis Oncology, Inc. Transaction History

Putnam Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$3.93 - $15.35 $551,056 - $2.15 Million	-140,218 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $3.31 Million - $6.62 Million	-258,057 Reduced 64.79%	140,218 $2.09 Million
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $10.4 Million - $17.8 Million	-587,228 Reduced 59.59%	398,275 $9.89 Million
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $1.07 Million - $3 Million	-91,680 Reduced 8.51%	985,503 $17.7 Million
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $13.9 Million - $23.4 Million	472,529 Added 78.15%	1,077,183 $31.6 Million
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $16 Million - $23.7 Million	-380,319 Reduced 38.61%	604,654 $27.5 Million
Q1 2018 May 15, 2018	BUY	$50.12 - $67.72 $9,522 - $12,866	190 Added 0.02%	984,973 $52 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $9.09 Million - $13.3 Million	157,628 Added 19.06%	984,783 $67 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $55.6 Million - $70.2 Million	827,155	827,155 $68.2 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.